Ocata Therapeutics Inc. OCAT
Set alert
At close · Jun 28
- Open
- 8.47
- Prev close
- 8.47
- Mkt cap
- 0
- Vol
- 1.12M
- Avg vol
- 521.34K
- EPS
- -6.58
- P/E
- -1.29
More statistics
- Low
- 8.45
- High
- 8.48
- Earnings
- Feb 15, 2016
News
10 years ago businesswire.com
Ocata Therapeutics to Host Conference Call and Webcast to Provide Corporate Update for the Third Quarter of 2015
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™ announced today that it will host a conference call on Monday,…
11 years ago businesswire.com
Ocata Therapeutics to Host Conference Call and Webcast to Provide Corporate Update for the Second Quarter of 2015
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, announced today that it will host a conference call on Thursday,…
11 years ago businesswire.com
Ocata Therapeutics to Host Conference Call and Webcast to Provide Corporate Update for the First Quarter of 2015
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, announced today that it will host a…
11 years ago businesswire.com
Ocata Therapeutics to Host Conference Call and Webcast to Provide Corporate Update for the Fourth Quarter and Full Year of 2014
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (“Ocata”; NASDAQ Global Market: OCAT), a clinical stage biotechnology company developing regenerative ophthalmology therapeutics,…